Aligos Therapeutics (ALGS) Short Interest Ratio & Short Volume $18.63 -2.22 (-10.65%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$19.14 +0.52 (+2.76%) As of 02/21/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Aligos Therapeutics Short Interest DataAligos Therapeutics (ALGS) has a short interest of 576,400 shares, representing 21.83% of the float (the number of shares available for trading by the public). This marks a -13.25% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 299,001 shares to cover all short positions.Current Short Interest576,400 sharesPrevious Short Interest664,400 sharesChange Vs. Previous Month-13.25%Dollar Volume Sold Short$14.87 millionShort Interest Ratio1.2 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares3,588,000 sharesFloat Size2,640,000 sharesShort Percent of Float21.83%Today's Trading Volume338,265 sharesAverage Trading Volume299,001 sharesToday's Volume Vs. Average113% Short Selling Aligos Therapeutics? Sign up to receive the latest short interest report for Aligos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALGS Short Interest Over TimeALGS Days to Cover Over TimeALGS Percentage of Float Shorted Over Time Aligos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025576,400 shares $14.87 million -13.3%21.8%1.2 $25.80 1/15/2025664,400 shares $21.08 million +11.2%25.2%1.5 $31.73 12/31/2024597,300 shares $23.80 million +30.7%22.4%1.4 $39.84 12/15/2024457,100 shares $15.57 million +61.1%17.1%1.3 $34.07 11/30/2024283,800 shares $7.24 million -2.6%11.2%0.9 $25.51 11/15/2024291,500 shares $5.59 million +140.3%11.5%1.1 $19.17 10/31/2024121,300 shares $1.19 million +46.5%4.8%0.8 $9.78 10/15/202482,800 shares $601,956.00 -31.0%3.7%1.3 $7.27 9/30/2024120,000 shares $1.04 million +245.8%5.3%2 $8.66 9/15/202434,700 shares $513,560.00 +132.9%1.5%0.6 $14.80 Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202414,900 shares $188,932.00 +18.3%0.7%0.4 $12.68 8/15/202412,600 shares $151,231.50 -95.5%0.6%0.6 $12.00 7/31/2024281,100 shares $146,172.00 +13.1%N/A0.7 $0.52 7/15/2024248,500 shares $126,710.15 -88.5%N/A0.6 $0.51 6/30/20242,160,000 shares $756,000.00 +16.8%N/A5.6 $0.35 6/15/20241,850,000 shares $925,000.00 -0.5%N/A6.2 $0.50 5/31/20241,860,000 shares $1.10 million +69.1%N/A6 $0.59 5/15/20241,100,000 shares $747,010.00 +31.2%N/A2.9 $0.68 4/30/2024838,500 shares $641,452.50 +27.6%N/A2.2 $0.77 4/15/2024657,200 shares $587,996.84 -24.4%N/A1.7 $0.89 3/31/2024868,800 shares $851,424.00 +137.6%N/A2.3 $0.98 3/15/2024365,600 shares $336,900.40 -1.0%N/A0.9 $0.92 2/29/2024369,100 shares $365,409.00 +16.4%N/A0.8 $0.99 2/15/2024317,100 shares $203,578.20 -64.6%N/A0.8 $0.64 1/31/2024894,500 shares $617,205.00 +6.4%N/A3 $0.69 1/15/2024840,400 shares $619,458.84 -1.7%N/A2.8 $0.74 12/31/2023855,200 shares $567,852.80 -1.1%N/A3.1 $0.66 12/15/2023864,400 shares $505,760.44 +14.2%N/A4.1 $0.59 11/30/2023756,900 shares $529,830.00 +4.4%2.4%4.6 $0.70 11/15/2023724,800 shares $456,624.00 -1.3%2.3%9.2 $0.63 10/31/2023734,600 shares $440,760.00 -3.4%4.1%10.1 $0.60 10/15/2023760,700 shares $562,918.00 +1.0%2.8%10.8 $0.74 9/30/2023753,300 shares $562,715.10 -1.6%2.8%10.7 $0.75 9/15/2023765,200 shares $612,160.00 +0.6%2.9%10.1 $0.80 8/31/2023761,000 shares $655,221.00 +2.6%2.9%7.7 $0.86 8/15/2023742,100 shares $693,863.50 -4.5%2.8%6.9 $0.94 7/31/2023776,800 shares $691,352.00 -3.3%2.8%3.5 $0.89 7/15/2023803,500 shares $827,605.00 -1.7%2.9%3.8 $1.03 6/30/2023817,600 shares $793,889.60 +4.1%3.0%3.9 $0.97 6/15/2023785,700 shares $864,270.00 -14.3%2.9%3.7 $1.10Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 5/31/2023917,000 shares $1.04 million +25.0%3.4%4.5 $1.13 5/15/2023733,500 shares $953,550.00 -5.3%2.7%3.6 $1.30 4/30/2023774,500 shares $898,420.00 -0.3%2.8%7.7 $1.16 4/15/2023776,800 shares $722,346.32 -6.8%2.8%5.8 $0.93 3/31/2023833,000 shares $728,042.00 -4.4%3.0%2.8 $0.87 3/15/2023871,200 shares $1.17 million +2.0%3.3%2.2 $1.34 2/28/2023853,900 shares $1.25 million +16.2%2.9%2.1 $1.46 2/15/2023735,100 shares $1.19 million +0.7%2.5%1.8 $1.62 1/31/2023730,300 shares $1.42 million +128.4%2.7%1.8 $1.94 1/15/2023319,800 shares $524,472.00 -17.6%1.2%0.9 $1.64 12/30/2022387,900 shares $369,629.91 -3.5%1.4%1.8 $0.95 12/15/2022402,100 shares $381,995.00 +3.2%1.5%4.6 $0.95 11/30/2022389,500 shares $389,500.00 -7.1%1.4%5.2 $1.00 11/15/2022419,300 shares $427,686.00 +17.6%1.5%5.7 $1.02 10/31/2022356,700 shares $374,535.00 +1.1%1.6%4.8 $1.05 10/15/2022353,000 shares $388,300.00 +4.6%1.6%4.5 $1.10 9/30/2022337,600 shares $371,360.00 -13.5%1.5%3.4 $1.10 9/15/2022390,300 shares $519,099.00 +11.7%1.7%2.6 $1.33 8/31/2022349,300 shares $436,625.00 -20.2%1.6%2.1 $1.25 8/15/2022437,800 shares $682,968.00 -13.3%2.0%2.1 $1.56 7/31/2022505,000 shares $626,200.00 -17.9%2.3%1.7 $1.24 7/15/2022614,800 shares $965,236.00 -72.4%2.8%1.9 $1.57 6/30/20222,230,000 shares $2.70 million -22.0%10.0%6.8 $1.21 6/15/20222,860,000 shares $3.75 million -3.4%12.9%7.8 $1.31 5/31/20222,960,000 shares $3.82 million +2.1%12.6%8.3 $1.29 5/15/20222,900,000 shares $3.39 million +11.5%12.3%7.8 $1.17 4/30/20222,600,000 shares $3.07 million +7.9%10.3%7.4 $1.18 4/15/20222,410,000 shares $3.74 million +4.8%9.5%5.7 $1.55 3/31/20222,300,000 shares $4.95 million +3.1%9.1%4 $2.15 3/15/20222,230,000 shares $5.26 million +5.7%8.8%4.1 $2.36 2/28/20222,110,000 shares $5.11 million +0.5%8.4%4.1 $2.42 2/15/20222,100,000 shares $5.54 million +3.5%8.3%4.3 $2.64 1/31/20222,030,000 shares $6.48 million +6.3%8.0%4.3 $3.19 1/15/20221,910,000 shares $6.49 million -15.5%7.3%5.4 $3.40 12/31/20212,260,000 shares $26.83 million +3.7%8.7%8.3 $11.87 12/15/20212,180,000 shares $27.14 million +2.8%8.4%11.9 $12.45 11/30/20212,120,000 shares $32.48 million +10.4%8.1%10.5 $15.32 11/15/20211,920,000 shares $32.35 million -3.5%7.4%9.6 $16.85 10/29/20211,990,000 shares $31.70 million +2.6%7.8%10.1 $15.93 10/15/20211,940,000 shares $30.87 million +2.1%7.6%9.3 $15.91 9/30/20211,900,000 shares $29.47 million +9.2%7.4%7.8 $15.51 9/15/20211,740,000 shares $28.28 million -3.3%6.8%5.6 $16.25 8/31/20211,800,000 shares $30.69 million -3.2%7.0%6.8 $17.05 8/13/20211,860,000 shares $29.24 million +1.1%7.3%7.2 $15.72 7/30/20211,840,000 shares $26.81 million +4.6%7.7%7.3 $14.57 7/15/20211,760,000 shares $27.24 million +2.9%7.3%8.2 $15.48 6/30/20211,710,000 shares $34.86 million +9.6%7.1%9 $20.39 6/15/20211,560,000 shares $44.43 million -0.6%7.2%18.2 $28.48 5/28/20211,570,000 shares $43.77 million -2.5%7.4%22.2 $27.88 5/14/20211,610,000 shares $36.40 million -1.2%8.2%25.2 $22.61Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 4/30/20211,630,000 shares $44.17 million +1.9%8.4%26.3 $27.10 4/15/20211,600,000 shares $34.53 million +3.2%7.8%24.1 $21.58 3/31/20211,550,000 shares $32.35 million No Change7.5%23 $20.87 3/15/20211,550,000 shares $40.52 million +3.3%7.5%13.2 $26.14 2/26/20211,500,000 shares $42.09 million +10.3%7.3%9.8 $28.06 2/12/20211,360,000 shares $31.73 million +3.8%6.6%8.3 $23.33 1/29/20211,310,000 shares $34.56 million +4.0%6.1%7.5 $26.38 1/15/20211,260,000 shares $43.02 million No Change5.8%6.8 $34.14 ALGS Short Interest - Frequently Asked Questions What is Aligos Therapeutics' current short interest? Short interest is the volume of Aligos Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 576,400 shares of ALGS short. 21.83% of Aligos Therapeutics' shares are currently sold short. Learn More on Aligos Therapeutics' current short interest. What is a good short interest ratio for Aligos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALGS shares currently have a short interest ratio of 1.0. Learn More on Aligos Therapeutics's short interest ratio. Which institutional investors are shorting Aligos Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aligos Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aligos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 21.83% of Aligos Therapeutics' floating shares are currently sold short. Is Aligos Therapeutics' short interest increasing or decreasing? Aligos Therapeutics saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 576,400 shares, a decline of 13.2% from the previous total of 664,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aligos Therapeutics' float size? Aligos Therapeutics currently has issued a total of 3,588,000 shares. Some of Aligos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aligos Therapeutics currently has a public float of 2,640,000 shares. How does Aligos Therapeutics' short interest compare to its competitors? 21.83% of Aligos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aligos Therapeutics: Monte Rosa Therapeutics, Inc. (17.56%), AnaptysBio, Inc. (23.27%), Astria Therapeutics, Inc. (6.64%), REGENXBIO Inc. (12.94%), Aura Biosciences, Inc. (2.72%), Taysha Gene Therapies, Inc. (11.75%), Revance Therapeutics, Inc. (4.32%), Terns Pharmaceuticals, Inc. (10.35%), Atai Life Sciences (9.67%), Phathom Pharmaceuticals, Inc. (21.40%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Aligos Therapeutics stock? Short selling ALGS is an investing strategy that aims to generate trading profit from Aligos Therapeutics as its price is falling. ALGS shares are trading down $2.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aligos Therapeutics? A short squeeze for Aligos Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALGS, which in turn drives the price of the stock up even further. How often is Aligos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALGS, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Monte Rosa Therapeutics Short Squeeze AnaptysBio Short Squeeze Astria Therapeutics Short Squeeze REGENXBIO Short Squeeze Aura Biosciences Short Squeeze Taysha Gene Therapies Short Squeeze Revance Therapeutics Short Squeeze Terns Pharmaceuticals Short Squeeze Atai Life Sciences Short Squeeze Phathom Pharmaceuticals Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALGS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aligos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
